Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,165.00    -15.00 (-1.27%)
Bid:
1,164.00
Ask:
1,166.00
Spread: 2.00 (0.172%)
Market Cap: £810.17m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

7 Oct 2008 07:00

RNS Number : 2159F
CVS Group plc
07 October 2008
 



For Immediate Release

7 October 2008

CVS Group plc

("CVS" or the "Company")

Acquisition of Rossendale Pet Crematorium Limited

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Rossendale Pet Crematorium Limited ('the crematorium').

 

The acquisition, which includes the freehold property from which the crematorium operates, has been financed wholly from the Company's cash flow, continuing to demonstrate the ability of the Company to finance its acquisition pipeline directly from internally generated cash.

 

Based in Lancashire, within a thirteen acre site, the crematorium and Memorial Gardens were established in 1967, aiming to provide bereaved pet owners with the best and widest options in coping with the death of their pets. 

CVS will assume all management responsibilities for the crematorium following completion of the acquisition including the nine current employees.

In the year ended 31 December 2007the crematorium achieved an Operating Profit of £136,000 on turnover of £490,000 and had gross assets of £503,000.

The acquisition of a crematorium will be a great enhancement to CVS' existing portfolio of 151 veterinary surgeries and veterinary laboratoriesFurther broadening the veterinary services offering, the acquisition provides a new division which, in line with CVS' stated strategy, will allow the Company to continue to generate stronger returns through vertical integration of key suppliers to the veterinary market.

CVS owned practices send minimal levels of work to the crematorium, therefore providing the opportunity for CVS surgeries to cascade work there post completion, where logistically suitable.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: 

"The acquisition of Rossendale Pet Crematorium is an important addition to the CVS group of businesses as well as a natural progression for our Company. In line with all acquisitions to date, it offers a high quality business with dedicated professionals.

The potential for cost synergies means that we will enhance our shareholder returns at the same time as improving our client offering."

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQILFITIVLRIIT
Date   Source Headline
15th Jan 20182:55 pmRNSExercise of Options & TVR
11th Jan 20189:48 amRNSHolding(s) in Company
9th Jan 20184:55 pmRNSHolding(s) in Company
5th Jan 20184:15 pmRNSHolding(s) in Company
4th Jan 20182:35 pmRNSHolding(s) in Company
2nd Jan 20188:35 amRNSTotal Voting Rights
2nd Jan 20187:00 amRNSDirectorate Change
29th Dec 201710:05 amRNSHolding(s) in Company
22nd Dec 20178:32 amRNSHolding(s) in Company
19th Dec 20177:00 amRNSBlock Admission
19th Dec 20177:00 amRNSExercise of Options, Directors' Dealing & TVR
18th Dec 20174:00 pmRNSHolding(s) in Company
13th Dec 20173:07 pmRNSExercise of Options & TVR
8th Dec 20174:39 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirector/PDMR Shareholding
7th Dec 20175:14 pmRNSHolding(s) in Company
30th Nov 20174:44 pmRNSTotal Voting Rights
30th Nov 20171:39 pmRNSResult of AGM
30th Nov 20177:00 amRNSAGM Statement
14th Nov 201712:12 pmRNSHolding(s) in Company
9th Nov 20174:15 pmRNSExercise of Options & TVR
2nd Nov 201710:33 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20174:14 pmRNSTotal Voting Rights
24th Oct 20172:41 pmRNSBlock listing Interim Review
24th Oct 20171:39 pmRNSExercise of Options & TVR
9th Oct 20174:57 pmRNSHolding(s) in Company
6th Oct 20174:23 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPreliminary Results
20th Sep 20175:24 pmRNSHolding(s) in Company
12th Sep 20173:41 pmRNSHolding(s) in Company
4th Sep 20172:53 pmRNSHolding(s) in Company
16th Aug 20173:46 pmRNSHolding(s) in Company
14th Aug 20173:10 pmRNSExercise of Options & TVR
31st Jul 201712:08 pmRNSExercise of Options & TVR
31st Jul 20177:00 amRNSTrading Update
26th Jul 20172:32 pmRNSHolding(s) in Company
25th Jul 20172:22 pmRNSExercise of Options & TVR
13th Jul 20173:39 pmRNSExercise of Options & TVR
7th Jul 20175:38 pmRNSHolding(s) in Company
4th Jul 20179:05 amRNSHolding(s) in Company
3rd Jul 20173:17 pmRNSExercise of Options & TVR
30th Jun 20173:59 pmRNSHolding(s) in Company
30th Jun 20172:57 pmRNSExercise of Options & TVR
2nd Jun 201711:38 amRNSHolding(s) in Company
26th May 20171:43 pmRNSHolding(s) in Company
25th May 20175:33 pmRNSExercise of Options & Total Voting Rights
24th May 20172:12 pmRNSHolding(s) in Company
16th May 20171:52 pmRNSHolding(s) in Company
3rd May 20173:44 pmRNSHolding(s) in Company
2nd May 20172:04 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.